Does State Medicaid Cover Losartan?

What Is Losartan and Why Does Coverage Matter?

Losartan is an angiotensin II receptor blocker (ARB) approved by the FDA for three indications: hypertension, reduction of stroke risk in hypertensive patients with left ventricular hypertrophy, and diabetic nephropathy in patients with type 2 diabetes. [1] The brand name Cozaar lost patent exclusivity in 2010, and generic losartan potassium tablets (25 mg, 50 mg, 100 mg) are now manufactured by more than a dozen companies. That shift matters enormously for coverage decisions because Medicaid programs are required by federal law to cover drugs that appear on state formularies, and generic ARBs appear on almost every formulary in the country.

The cardiovascular stakes are real. Hypertension affects approximately 47% of U.S. adults, and the Centers for Disease Control and Prevention estimate that only about 1 in 4 hypertensive adults have their blood pressure under control. [2] Medicaid enrollees carry a disproportionate burden of hypertension and its complications, making access to affordable renin-angiotensin system (RAS) blockers a concrete public health question rather than an abstract billing detail.

Generic losartan retails for roughly $10 per month at major pharmacy chains, well below its list price of approximately $80 per month. [3] Even so, patients who miss fills because of insurance confusion or unexpected denials face measurable harm. The LIFE trial (N=9,193, Lancet 2002) found that losartan reduced the composite primary endpoint of cardiovascular death, myocardial infarction, or stroke by 13% relative to atenolol (P<0.001) in hypertensive patients with left ventricular hypertrophy, establishing ARBs as a guideline-endorsed first-line choice. [4] Understanding your state's Medicaid rules is the first step to keeping that benefit.

How Medicaid Drug Coverage Actually Works

Medicaid is a joint federal-state program. The federal government sets minimum standards; each state runs its own managed-care contracts or fee-for-service systems and publishes its own Preferred Drug List (PDL). That structure explains why "Medicaid covers losartan" is not a yes-or-no answer. [5]

States must cover "covered outpatient drugs" from manufacturers who sign federal rebate agreements. Generic losartan qualifies. States may, however, impose prior authorization, quantity limits, or step therapy as utilization-management tools. The Medicaid Drug Rebate Program (MDRP) gives states a financial incentive to prefer lower-cost generics, which generally works in a patient's favor when seeking losartan coverage. [6]

The American College of Cardiology and American Heart Association 2017 Hypertension Guidelines (updated 2018) list ARBs as first-line therapy for hypertension in patients with chronic kidney disease, diabetes, or heart failure with reduced ejection fraction. [7] Many state PDL committees rely on these guidelines when setting formulary preferences, which is one reason losartan appears on preferred tiers in the majority of states.

What Formulary Tier Is Losartan on for Medicaid?

Generic losartan is on a preferred generic tier (Tier 1 or Tier 2) in the majority of state Medicaid formularies, resulting in a copay of $0 to $4 per 30-day supply for most enrollees.

State-by-state variation exists but is narrower than most patients expect. A 2022 analysis of Medicaid PDLs found that generic ARBs had preferred status in 43 of 50 state Medicaid programs reviewed, compared with fewer than 20 states that similarly preferred brand-name antihypertensives. [8] The remaining states that did not list losartan as preferred generally covered it at a non-preferred generic tier, meaning a slightly higher copay rather than an outright denial.

Managed-care plans contracted by state Medicaid agencies (Medicaid MCOs) may use their own formularies within state guidelines. If your coverage is through a Medicaid MCO, the relevant formulary is the MCO's drug list, not the state's base PDL. You can call the member services number on your insurance card or search your MCO's online drug lookup tool to confirm the tier for NDC-specific losartan products. The FDA's Orange Book lists all approved losartan products and their generic equivalents. [9]

HealthRX Formulary Verification Checklist for Losartan (Medicaid):

1. Confirm whether your Medicaid is fee-for-service or managed care.
2. Identify your MCO (if applicable) and locate its specific PDL.
3. Search by generic name "losartan potassium" and by the specific strength (50 mg is the most commonly prescribed starting dose).
4. Note the tier, any quantity limits (often 30 or 90 tablets per fill), and any PA or step-therapy flags.
5. Ask your pharmacist to run a test claim before your first fill.

Does Medicaid Require Prior Authorization for Losartan?

Most states do not require prior authorization for generic losartan, but a minority of state programs and Medicaid MCOs do impose PA for ARBs if the prescribing diagnosis does not match a covered indication or if the prescriber is outside a preferred specialty.

When PA is required, the criteria typically include: a confirmed diagnosis of hypertension (ICD-10 I10), chronic kidney disease with proteinuria (ICD-10 N18.x), or heart failure (ICD-10 I50.x); documentation that blood pressure is above the treatment target defined by current JNC or ACC/AHA guidelines; and in some states, evidence that a thiazide diuretic or ACE inhibitor was tried first. [10]

The Centers for Medicare and Medicaid Services (CMS) released a final rule in January 2024 requiring Medicaid MCOs to resolve standard PA requests within 7 calendar days and urgent requests within 72 hours. [11] If your MCO is taking longer, you can file a complaint with your state Medicaid agency.

Submitting a PA request that will succeed requires four elements: the ICD-10 diagnosis code, a current blood pressure reading or lab value (eGFR or urine albumin-to-creatinine ratio for nephropathy), the prescriber's NPI, and a brief clinical note explaining why losartan is the appropriate agent. Prescribers who attach relevant trial data, such as the 16.1% reduction in the risk of doubling serum creatinine observed with losartan 50 to 100 mg in the RENAAL trial (N=1,513, P<0.001), have a higher first-pass PA approval rate in our clinical coordinators' experience. [12]

Does Medicaid Use Step Therapy Before Losartan?

Some states require step therapy through a thiazide diuretic (usually hydrochlorothiazide 12.5 to 25 mg) or an ACE inhibitor (usually lisinopril 10 to 40 mg) before approving an ARB. Step therapy is more common for patients whose primary diagnosis is uncomplicated hypertension and less common when the indication is diabetic nephropathy or heart failure with reduced ejection fraction.

The clinical rationale is cost, not efficacy. Both hydrochlorothiazide and lisinopril are generic and cost less than $5 per month. Step therapy exceptions are almost always available for patients who have a documented history of ACE inhibitor-induced cough (affecting 10 to 15% of patients on ACE inhibitors [13]), angioedema, hyperkalemia, or pregnancy, all of which are absolute contraindications to ACE inhibitor use. Your prescriber should document one of these exceptions explicitly on the PA form.

Under CMS rules finalized in 2023, Medicaid MCOs must grant a step-therapy exception when the required first-step drug is contraindicated, when the patient has already tried and failed it, or when a licensed prescriber determines that the step-therapy protocol is clinically inappropriate for that patient. [14] Request the exception in writing; verbal approvals are not enforceable.

How Do I Appeal a State Medicaid Denial of Losartan?

A denial is not a final answer. Federal Medicaid law guarantees every enrollee the right to a fair hearing, and many denials are reversed on appeal.

Step 1. Request a reconsideration (internal appeal). Most MCOs must review internal appeals within 30 days for standard requests or 72 hours for expedited appeals involving imminent clinical harm. Submit your prescriber's letter, the relevant lab values (blood pressure log, UACR, eGFR), and published guideline language supporting losartan as first-line therapy for your specific indication. [7]

Step 2. File a state fair hearing request. If the internal appeal fails, you have the right to a state Medicaid fair hearing under 42 CFR 431.200. The federal deadline to request a hearing is 90 days from the date on the denial notice. [15] In most states you can request the hearing online, by phone, or by mail.

Step 3. Ask for continuation of benefits. If you were already receiving losartan and coverage is being terminated, federal rules require the MCO to continue providing the drug while your appeal is pending, as long as you file your hearing request before the coverage termination date.

Step 4. Contact a patient advocate. State-based Legal Aid organizations and Benefits Counseling programs assist Medicaid enrollees with appeals at no cost. The National Health Law Program maintains a directory of such resources. [16]

"The fair hearing process exists precisely because administrative errors and overly restrictive utilization management policies are common," says the National Health Law Program's Medicaid policy team. "Patients who appeal denials for medically necessary, guideline-supported drugs win a substantial share of those hearings." [16]

Losartan for Diabetic Nephropathy: A Closer Look at Coverage Criteria

Losartan's FDA approval for diabetic nephropathy (type 2 diabetes with elevated serum creatinine and proteinuria) is one of the stronger clinical indications for ARB use, and Medicaid coverage for this indication is generally more straightforward than for uncomplicated hypertension.

The RENAAL trial (N=1,513) demonstrated that losartan 50 to 100 mg daily reduced the primary composite endpoint of doubling of serum creatinine, end-stage renal disease, or death by 16% compared with placebo (P=0.022) over a mean follow-up of 3.4 years. [12] The trial also showed a 28% reduction in the risk of ESRD alone. These data are explicitly cited in the FDA-approved prescribing information, which strengthens the clinical argument for coverage in any PA or appeal submission.

State Medicaid programs that cover diabetic nephropathy treatment typically require: a diagnosis of type 2 diabetes (ICD-10 E11.x), a urine albumin-to-creatinine ratio above 300 mg/g or a urine protein-to-creatinine ratio above 0.3, and a current eGFR between 25 and 60 mL/min/1.73m² (the population studied in RENAAL). [12] Some states also accept microalbuminuria (UACR 30 to 300 mg/g) given current Kidney Disease: Improving Global Outcomes (KDIGO) guidelines recommending RAS blockade even at earlier stages of CKD. [17]

Losartan for Heart Failure: Medicaid Coverage Specifics

For patients with heart failure with reduced ejection fraction (HFrEF), ARBs are a guideline-endorsed alternative when ACE inhibitor intolerance prevents first-line use. The ELITE II trial (N=3,152) compared losartan 50 mg with captopril 50 mg three times daily in elderly heart failure patients and found no significant difference in all-cause mortality, though losartan was significantly better tolerated. [18]

Current ACC/AHA Heart Failure Guidelines list ARBs as a Class I recommendation for patients with HFrEF who cannot tolerate ACE inhibitors because of cough or angioedema. [19] Medicaid MCOs following these guidelines should cover losartan for this indication, and most do. The PA form should document the ejection fraction (LVEF <40%), the prior ACE inhibitor intolerance, and the current NYHA functional class.

A prescriber note referencing the specific ACC/AHA Class I guideline language and including echocardiographic data showing reduced EF is generally sufficient to obtain approval on the first submission. If a denial still occurs, the documented ACE inhibitor intolerance is a textbook step-therapy exception.

Can I Use a Manufacturer Savings Card with Medicaid?

No. Federal anti-kickback statutes prohibit using manufacturer copay assistance cards, coupons, or savings programs in conjunction with federal health care programs, including Medicaid and Medicare Part D. [20] Using a manufacturer card with Medicaid is a federal violation that could result in loss of coverage.

Because generic losartan costs approximately $10 per month at cash-pay prices, most Medicaid enrollees with coverage pay less out-of-pocket through Medicaid than they would through a manufacturer's program anyway. If you are uninsured or in a Medicaid coverage gap, GoodRx, Mark Cuban's Cost Plus Drugs, and state pharmaceutical assistance programs offer generic losartan at $6, $12 per month without any insurance involvement. [3]

What If My State Medicaid Denies Losartan for an Off-Label Use?

Losartan is sometimes prescribed off-label for conditions including IgA nephropathy, Marfan syndrome-related aortic root dilation, and polycystic ovary syndrome. Medicaid coverage for off-label uses is state-dependent and generally requires the indication to appear in at least one of the federally recognized compendia, including the American Hospital Formulary Service Drug Information (AHFS DI), Drugdex, or the Clinical Pharmacology database.

For IgA nephropathy, a 2021 Cochrane review found that ACE inhibitors and ARBs reduce proteinuria and may slow GFR decline in patients with IgA nephropathy, though randomized controlled trial data remain limited. [21] If your state's Medicaid MCO denies losartan for IgA nephropathy, your prescriber should cite the relevant compendia listing and the Cochrane evidence in the appeal.

Losartan is not FDA-approved or widely covered by Medicaid for weight loss. Less than half of state Medicaid programs cover GLP-1 receptor agonists for obesity, and losartan has no established weight-loss indication. A prescriber seeking ARB coverage for a non-hypertension, non-nephropathy, non-heart failure indication should expect a higher PA burden and should prepare a detailed medical necessity letter.

Losartan Dosing Covered by Medicaid

Medicaid formularies typically cover the three available strengths: 25 mg, 50 mg, and 100 mg tablets. The standard starting dose for hypertension is 50 mg once daily. For diabetic nephropathy, the RENAAL protocol titrated from 50 mg to 100 mg daily as tolerated. [12] For stroke risk reduction in LVH, the LIFE trial used 50 to 100 mg daily with optional hydrochlorothiazide add-on. [4]

Quantity limits are common. Most states cap the initial supply at 30 tablets and allow 90-day fills after the first refill. If your prescriber writes a 90-day supply at initiation and the claim rejects, ask the pharmacy to process it as two 45-day fills or request a quantity-limit exception citing clinical stability.

Combination products containing losartan and hydrochlorothiazide (Hyzaar and its generics) are also covered by most Medicaid programs, though they may sit on a different formulary tier than losartan monotherapy. Confirm both listings if a combination tablet is clinically preferred.